Nicotinamide Riboside and Metabolic Health

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study will investigate the effects of 6 week Nicotinamide Riboside supplementation (1000 mg/day) on metabolic health in healthy (pre)obese humans. The primary objective will be hepatic and whole body insulin sensitivity. Secondary objectives, to provide information about the underlying mechanism, will be muscle mitochondrial function, brown fat activity, ectopic lipid accumulation, energy metabolism, cardiovascular risk parameters, body composition and acetylcarnitine levels.
Epistemonikos ID: 672c862df9b45024b59501a8edfda62c2c11f8a5
First added on: May 17, 2024